PMFA
HAE icon

Plante Moran Financial Advisors’s Haemonetics HAE Stock Holding History

Plante Moran Financial Advisors’s Portfolio HAE Stock Details HAE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-21
Closed -$1K – 931
2015
Q4 		$1K Buy
+21
New +$681 ﹤0.01% 905

Other funds holding HAE

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
BCIM
Black Creek Investment Management Toronto, Ontario, Canada $1.86B AUM 15.33% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
WHG
Westwood Holdings Group Dallas, Texas $13.7B AUM 21.48% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Plante Moran Financial Advisors's HAE Position: Q1 2016 in Review

Plante Moran Financial Advisors sold out of Haemonetics (HAE) in Q1 2016, closing a stake of 21 shares — an estimated $1K sold.

Plante Moran Financial Advisors first reported a position in HAE in Q4 2015 and held it in 1 quarter. The position peaked at $1K in Q4 2015. 170 funds tracked by Wall St. Rank hold HAE as of Q1 2016.

  • Plante Moran Financial Advisors reported no remaining Haemonetics position as of Q1 2016 after selling out during the quarter.
  • Plante Moran Financial Advisors sold 21 Haemonetics shares in Q1 2016, an estimated $1K.
  • Plante Moran Financial Advisors first reported a position in Haemonetics in Q4 2015 and held it in 1 quarter.
  • Plante Moran Financial Advisors's Haemonetics position peaked at $1K in Q4 2015.
  • 170 funds tracked by Wall St. Rank held Haemonetics as of Q1 2016.

Based on Plante Moran Financial Advisors's 13F filing for Q1 2016, filed 26 Apr 2016.